Table 3. NK-cell content in PB and BM of... | American Society of Hematology

Table 3.

NK-cell content in PB and BM of patients after allogeneic SCT

	PB NK cells			BM NK cells
	% TNCs	× 10^-4/mL	% TNCs	× 10^-4/mL
Donors (n = 13/6)	3.31 ± 0.74	19.46 ± 4.35	0.76 ± 0.24	11.08 ± 3.01
Patients after SCT
Day 7 (n = 5/0)	1.98 ± 1.6	0.50 ± 0.34*	ND	ND
Day 14 (n = 16/8)	1.84 ± 0.44†	6.05 ± 1.82*	0.97 ± 0.30	8.53 ± 2.13
Day 30 (n = 16/14)	1.64 ± 0.22†	10.62 ± 2.30†	0.99 ± 0.30	8.87 ± 3.47
Day 90 (n = 15/12)	3.09 ± 0.73	8.20 ± 1.83†	1.18 ± 0.36	9.77 ± 2.66
Day 180 (n = 9/7)	3.08 ± 0.64	12.72 ± 2.15	1.35 ± 0.31	13.68 ± 5.00

	PB NK cells			BM NK cells
	% TNCs	× 10^-4/mL	% TNCs	× 10^-4/mL
Donors (n = 13/6)	3.31 ± 0.74	19.46 ± 4.35	0.76 ± 0.24	11.08 ± 3.01
Patients after SCT
Day 7 (n = 5/0)	1.98 ± 1.6	0.50 ± 0.34*	ND	ND
Day 14 (n = 16/8)	1.84 ± 0.44†	6.05 ± 1.82*	0.97 ± 0.30	8.53 ± 2.13
Day 30 (n = 16/14)	1.64 ± 0.22†	10.62 ± 2.30†	0.99 ± 0.30	8.87 ± 3.47
Day 90 (n = 15/12)	3.09 ± 0.73	8.20 ± 1.83†	1.18 ± 0.36	9.77 ± 2.66
Day 180 (n = 9/7)	3.08 ± 0.64	12.72 ± 2.15	1.35 ± 0.31	13.68 ± 5.00

All numbers are expressed as mean ± SEM; % TNCs is percent of total nucleated cells. n indicates number of PB/BM samples analyzed at each time point; ND, not done.

P < .005 compared with healthy controls.

†

P < .05 compared with healthy controls.

View Large

This Feature Is Available To Subscribers Only